Pharmaceuticals in India
Pharmaceuticals in India
SUMMARY
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indian pharmaceuticals market had total revenues of $32,500.0m in 2019, representing a compound annual growth rate (CAGR) of 2.2% between 2015 and 2019.
- The Indian market is growing, driven by an increase in real GDP, doctors and India’s population covered by insurance. A number of major government initiatives are set to support this growth in the future
- The Indian market supplies around 40% of generic demand in the US and 25% of all medicine in the UK. Around 80% of the world’s antiretroviral drugs used in the treatment of HIV/AIDs are made in India.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
- What was the size of the India pharmaceuticals market by value in 2019?
- What will be the size of the India pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in India's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Lupin Ltd
8.2. Sun Pharmaceutical Industries Inc
8.3. Aurobindo Pharma Ltd
8.4. Dr. Reddy's Laboratories Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Lupin Ltd
8.2. Sun Pharmaceutical Industries Inc
8.3. Aurobindo Pharma Ltd
8.4. Dr. Reddy's Laboratories Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: India pharmaceuticals market value: $ billion, 2015-19
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: India pharmaceuticals market share: % share, by value, 2019
Table 5: Lupin Ltd: key facts
Table 6: Lupin Ltd: Annual Financial Ratios
Table 7: Lupin Ltd: Key Employees
Table 8: Lupin Ltd: Key Employees Continued
Table 9: Sun Pharmaceutical Industries Inc: key facts
Table 10: Sun Pharmaceutical Industries Inc: Key Employees
Table 11: Aurobindo Pharma Ltd: key facts
Table 12: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 13: Aurobindo Pharma Ltd: Key Employees
Table 14: Dr. Reddy's Laboratories Limited: key facts
Table 15: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 16: Dr. Reddy's Laboratories Limited: Key Employees
Table 17: Dr. Reddy's Laboratories Limited: Key Employees Continued
Table 18: India size of population (million), 2015-19
Table 19: India gdp (constant 2005 prices, $ billion), 2015-19
Table 20: India gdp (current prices, $ billion), 2015-19
Table 21: India inflation, 2015-19
Table 22: India consumer price index (absolute), 2015-19
Table 23: India exchange rate, 2015-19
Table 1: India pharmaceuticals market value: $ billion, 2015-19
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: India pharmaceuticals market share: % share, by value, 2019
Table 5: Lupin Ltd: key facts
Table 6: Lupin Ltd: Annual Financial Ratios
Table 7: Lupin Ltd: Key Employees
Table 8: Lupin Ltd: Key Employees Continued
Table 9: Sun Pharmaceutical Industries Inc: key facts
Table 10: Sun Pharmaceutical Industries Inc: Key Employees
Table 11: Aurobindo Pharma Ltd: key facts
Table 12: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 13: Aurobindo Pharma Ltd: Key Employees
Table 14: Dr. Reddy's Laboratories Limited: key facts
Table 15: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 16: Dr. Reddy's Laboratories Limited: Key Employees
Table 17: Dr. Reddy's Laboratories Limited: Key Employees Continued
Table 18: India size of population (million), 2015-19
Table 19: India gdp (constant 2005 prices, $ billion), 2015-19
Table 20: India gdp (current prices, $ billion), 2015-19
Table 21: India inflation, 2015-19
Table 22: India consumer price index (absolute), 2015-19
Table 23: India exchange rate, 2015-19
LIST OF FIGURES
Figure 1: India pharmaceuticals market value: $ billion, 2015-19
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in India, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in India, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in India, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019
Figure 10: India pharmaceuticals market share: % share, by value, 2019
Figure 1: India pharmaceuticals market value: $ billion, 2015-19
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in India, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in India, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in India, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019
Figure 10: India pharmaceuticals market share: % share, by value, 2019
